No Director's interest change = no new AJQ shares acquired by Mather. The shortfall under the Rights Issue was placed to third parties.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025